Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose LY2245461 in healthy postmenopausal women with hot flashes
2008-001372-75Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of LY2245461 in hot flash, sponsored by Eli Lilly and Company. Primary endpoint: Safety evaluations. Started Apr 2008; status: completed.
02
Drugs
LY2245461
03
Conditions
hot flash
Beyond the preview
Go deeper on 2008-001372-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001372-75.